David Hsiehchen - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

David Hsiehchen

Showing results (61-70 of 63) with videos related to

Pageof 7

Sort By:

You have reached the last page of results.This site can display upto 63 results.

Nature Cancer|June 27, 2025

Profiling antigen-binding affinity of B cell repertoires in tumors by deep learning predicts immune-checkpoint inhibitor treatment outcomesBing Song, Kaiwen Wang, Saiyang Na, et al.

Nature Communications|June 13, 2026

Deciphering small sequence differences in T cell receptor-antigen pairingYi Han, Yuqiu Yang, James Zhu, et al.

JHEP Reports : Innovation in Hepatology|December 29, 2022

Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinomaBernhard Scheiner, Daniel Roessler, Samuel Phen, et al.

Pageof 7

Search research articles

Showing results (61-70 of 63) with videos related to

Sort By:

Pageof 7

You have reached the last page of results.This site can display upto 63 results.

Nature Cancer|June 27, 2025

Profiling antigen-binding affinity of B cell repertoires in tumors by deep learning predicts immune-checkpoint inhibitor treatment outcomesBing Song, Kaiwen Wang, Saiyang Na, et al.

Nature Communications|June 13, 2026

Deciphering small sequence differences in T cell receptor-antigen pairingYi Han, Yuqiu Yang, James Zhu, et al.

JHEP Reports : Innovation in Hepatology|December 29, 2022

Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinomaBernhard Scheiner, Daniel Roessler, Samuel Phen, et al.

Pageof 7